Equities research analysts expect that MedEquities Realty Trust Inc (NYSE:MRT) will announce sales of $16.08 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for MedEquities Realty Trust’s earnings, with estimates ranging from $15.14 million to $16.79 million. MedEquities Realty Trust reported sales of $16.72 million during the same quarter last year, which indicates a negative year-over-year growth rate of 3.8%. The firm is expected to issue its next quarterly earnings results on Thursday, May 9th.

On average, analysts expect that MedEquities Realty Trust will report full year sales of $65.86 million for the current fiscal year, with estimates ranging from $62.16 million to $67.90 million. For the next fiscal year, analysts expect that the business will post sales of $70.80 million, with estimates ranging from $70.29 million to $71.30 million. Zacks’ sales calculations are a mean average based on a survey of analysts that that provide coverage for MedEquities Realty Trust.

Several research analysts recently weighed in on the stock. ValuEngine raised shares of MedEquities Realty Trust from a “hold” rating to a “buy” rating in a report on Tuesday, January 29th. Zacks Investment Research raised shares of MedEquities Realty Trust from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 22nd. JPMorgan Chase & Co. raised shares of MedEquities Realty Trust from an “underweight” rating to a “neutral” rating in a report on Wednesday, January 2nd. Raymond James downgraded shares of MedEquities Realty Trust to a “market perform” rating in a report on Friday, January 4th. Finally, B. Riley reaffirmed a “neutral” rating and issued a $10.00 target price (down previously from $10.50) on shares of MedEquities Realty Trust in a report on Thursday, January 3rd. Ten investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $10.89.

In other MedEquities Realty Trust news, Director Bluemountain Capital Managemen sold 362,699 shares of the stock in a transaction dated Thursday, January 24th. The shares were sold at an average price of $10.94, for a total transaction of $3,967,927.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold a total of 797,138 shares of company stock valued at $8,818,086 in the last three months. Insiders own 3.00% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Virtu Financial LLC bought a new position in shares of MedEquities Realty Trust during the 1st quarter valued at about $257,000. Geode Capital Management LLC increased its holdings in MedEquities Realty Trust by 4.0% in the fourth quarter. Geode Capital Management LLC now owns 342,450 shares of the financial services provider’s stock valued at $2,341,000 after buying an additional 13,014 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in MedEquities Realty Trust by 36.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 141,972 shares of the financial services provider’s stock valued at $971,000 after buying an additional 37,553 shares in the last quarter. D. E. Shaw & Co. Inc. increased its holdings in MedEquities Realty Trust by 191.4% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 70,090 shares of the financial services provider’s stock valued at $479,000 after buying an additional 46,038 shares in the last quarter. Finally, Bank of America Corp DE increased its holdings in MedEquities Realty Trust by 89.4% in the fourth quarter. Bank of America Corp DE now owns 21,826 shares of the financial services provider’s stock valued at $150,000 after buying an additional 10,305 shares in the last quarter. 88.20% of the stock is owned by institutional investors and hedge funds.

NYSE MRT traded down $0.13 during mid-day trading on Friday, reaching $10.47. The stock had a trading volume of 52,513 shares, compared to its average volume of 261,628. MedEquities Realty Trust has a 1 year low of $6.27 and a 1 year high of $11.85. The firm has a market cap of $337.51 million, a P/E ratio of 9.18 and a beta of 1.72.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Further Reading: Mutual Funds

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.